- Trials with a EudraCT protocol (31)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
31 result(s) found for: Hypoxic hypoxia.
Displaying page 1 of 2.
EudraCT Number: 2008-005985-30 | Sponsor Protocol Number: rosucaf2 | Start Date*: 2009-01-22 | |||||||||||
Sponsor Name:Department of Pharmacology-Toxicology | |||||||||||||
Full Title: Is augmentation of PORH by rosuvastatin adenosine-receptor mediated? | |||||||||||||
Medical condition: mechanism of influence of statins on human adaptive mechanisms in hypoxic circumstances | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-002251-33 | Sponsor Protocol Number: 01 | Start Date*: 2006-10-10 |
Sponsor Name:University of Vienna | ||
Full Title: Hypoxia Imaging with the novel Radiopharmaceutical 18F Fluoroazomycin Arabinoside (FAZA)- Prognostic impact in Cervical Cancer . | ||
Medical condition: Twenty-five patients with cervical carcinoma (T2Nx or TxN1) will be included in the present study. In addition to the routine pre-therapeutical staging of cervical cancer, 18FAZA PET will be perfor... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Female | |
Trial protocol: AT (Completed) | ||
Trial results: View results |
EudraCT Number: 2020-003363-25 | Sponsor Protocol Number: NA | Start Date*: 2020-08-18 | ||||||||||||||||
Sponsor Name:Department of Intensive Care, Rigshospitalet | ||||||||||||||||||
Full Title: Higher vs. Lower Doses of Dexamethasone in Patients with COVID-19 and Severe Hypoxia: the COVID STEROID 2 trial | ||||||||||||||||||
Medical condition: Adult patients with COVID-19 and severe hypoxia. | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: DK (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2015-005222-19 | Sponsor Protocol Number: BREATH | Start Date*: 2016-07-14 | |||||||||||
Sponsor Name:Leiden University Medical Center | |||||||||||||
Full Title: Effect of neuromuscular blockade and reversal by sugammadex versus neostigmine on breathing when hypoxic or hypercapnic in volunteers | |||||||||||||
Medical condition: Postoperative ventilatory control | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2010-021139-15 | Sponsor Protocol Number: ESC-928-MOL-0000-I | Start Date*: Information not available in EudraCT | |||||||||||
Sponsor Name:Technische Universität München Fakultät für Medizin | |||||||||||||
Full Title: Do Selective Radiation Dose Escalation and Tumor Hypoxia Status Impact the Locoregional Tumor Control after Radiochemotherapy of Head & Neck Tumors? | |||||||||||||
Medical condition: This study tests the hypothesis that the Radiation dose escalation to the macroscopic Tumor improves the locoregional control survival after concomitant chemoradiation over 2 years. As a transla... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2015-004133-27 | Sponsor Protocol Number: DAHANCA30 | Start Date*: 2016-04-18 |
Sponsor Name:Århus Universitetshospital Afd for Eksp. Klinisk onkologi | ||
Full Title: A randomized non-inferiority trial of hypoxia-profile guided hypoxic modification with nimorazole during radiotherapy/chemoradiotherapy of squamous cell carcinoma of the head and neck | ||
Medical condition: Patients with squamous cell carcinoma of the head and neck | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DK (Trial now transitioned) | ||
Trial results: (No results available) |
EudraCT Number: 2016-003621-41 | Sponsor Protocol Number: DESIRED | Start Date*: 2016-12-05 |
Sponsor Name:Department of Endocrinology, Metabolism and Diabetes, Karolinska University Hospital | ||
Full Title: Desferal administration to improve the impaired reaction to hypoxia in diabetes (DESIRED) A randomised, double-blind, placebo-controlled, cross-over study | ||
Medical condition: The study will investigate the effect of deferoxamine on the impaired reaction to hypoxia in patients with diabetes mellitus type 1. | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: SE (Trial now transitioned) | ||
Trial results: (No results available) |
EudraCT Number: 2015-003063-12 | Sponsor Protocol Number: NEU-01-02-1A | Start Date*: 2016-09-14 | ||||||||||||||||||||||||||||||||||||||||||||||
Sponsor Name:Neurophyxia B.V. | ||||||||||||||||||||||||||||||||||||||||||||||||
Full Title: TIBC study: A multiple-centre Phase 2 trial comparing the efficacy of 2-Iminobiotin (2-IB) treatment to standard care in neonates with gestational age of ≥36 weeks with moderate to severe perinatal... | ||||||||||||||||||||||||||||||||||||||||||||||||
Medical condition: Perinatal asphyxia | ||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||
Population Age: Preterm newborn infants, Newborns, Under 18 | Gender: Male, Female | |||||||||||||||||||||||||||||||||||||||||||||||
Trial protocol: Outside EU/EEA | ||||||||||||||||||||||||||||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-000057-27 | Sponsor Protocol Number: 72544 | Start Date*: 2021-10-27 |
Sponsor Name:Leiden University Medical Center | ||
Full Title: Recovery of carotid body function after full recovery neuromuscular block | ||
Medical condition: Postoperative ventilatory control | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2020-001375-32 | Sponsor Protocol Number: PreToVid | Start Date*: 2020-04-03 |
Sponsor Name:UMCG | ||
Full Title: Pre-emptive tocilizumab in hypoxic COVID-19 patients, a prospective randomized trial | ||
Medical condition: Hypoxia | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Completed) | ||
Trial results: View results |
EudraCT Number: 2015-005278-40 | Sponsor Protocol Number: ABR-55752 | Start Date*: 2016-11-29 | |||||||||||
Sponsor Name:Radboudumc | |||||||||||||
Full Title: Molecular imaging before and during (chemo-) radiotherapy in patients with locally advanced Head and Neck, thoracic and pelvic tumors: prognostic and predictive value of 18F-fluoroazomycin arabinos... | |||||||||||||
Medical condition: Head and neck squamous cell carcinoma (HNSCC) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2018-004119-36 | Sponsor Protocol Number: METOXY-LACC | Start Date*: 2019-11-04 | |||||||||||
Sponsor Name:Oslo University Hospital | |||||||||||||
Full Title: Altered tumor oxygenation by Metformin, a potential step in overcoming radiotherapy resistance in locally advanced cervical cancer. | |||||||||||||
Medical condition: Locally advanced cervical cancer | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Female | ||||||||||||
Trial protocol: NO (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2013-002441-12 | Sponsor Protocol Number: 1219 | Start Date*: 2013-12-16 | |||||||||||
Sponsor Name:European Organisation for Research and Treatment of Cancer | |||||||||||||
Full Title: A blind randomized multicenter study of accelerated fractionated chemo-radiotherapy with or without the hypoxic radiosensitizer nimorazole (Nimoral), using a 15 gene signature for hypoxia in the tr... | |||||||||||||
Medical condition: Squamous cell carcinoma of the head and neck | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) NL (Completed) PL (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2012-005812-24 | Sponsor Protocol Number: MalinJonssonFagerlund10 | Start Date*: 2013-05-02 | ||||||||||||||||
Sponsor Name:Karolinska University Hospital | ||||||||||||||||||
Full Title: Acute ventilatory response to hypoxia during sedation with dexmedetomidine compared to propofol in healthy volunteers. | ||||||||||||||||||
Medical condition: Healthy volunteers and the acute hypoxic ventilatory response during sedation with dexmedetomidine compared to propofol. | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Male | |||||||||||||||||
Trial protocol: SE (Completed) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-000528-17 | Sponsor Protocol Number: IAEA-HypoX | Start Date*: 2012-06-05 |
Sponsor Name:Department of Experimental Clinical Oncology | ||
Full Title: A randomized multicenter study of accelerated fractionated radiotherapy with or without the hypoxic radiosensitizer nimorazole in the treatment of squamous cell carcinoma of the head and neck | ||
Medical condition: Squamous Cell Carcinoma of the Head and Neck region | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: SI (Completed) EE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2006-005796-18 | Sponsor Protocol Number: 03-217 | Start Date*: 2009-07-21 | ||||||||||||||||
Sponsor Name:WKZ / UMC Utrecht | ||||||||||||||||||
Full Title: Does antenatal allopurinol during asphyxia reduce post-hypoxic-ischemic reperfusion damage in the newborn? | ||||||||||||||||||
Medical condition: Perinatal asphyxia | ||||||||||||||||||
|
||||||||||||||||||
Population Age: In utero, Preterm newborn infants, Newborns, Under 18, Adults | Gender: Male, Female | |||||||||||||||||
Trial protocol: NL (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-000936-17 | Sponsor Protocol Number: GWEP1560 | Start Date*: 2019-07-23 | ||||||||||||||||
Sponsor Name:GW Research Ltd | ||||||||||||||||||
Full Title: A Randomized, Double-Blind, Placebo-Controlled Single-Ascending Dose Trial to Evaluate the Safety, Tolerability, and Pharmacokinetics of GWP42003-P in Conjunction with Hypothermia in Neonates with ... | ||||||||||||||||||
Medical condition: Neonatal Hypoxic-Ischemic Encephalopathy | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Preterm newborn infants, Newborns, Under 18 | Gender: Male, Female | |||||||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) ES (Completed) PL (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2016-000497-38 | Sponsor Protocol Number: DEX-PCH-VMNI | Start Date*: 2016-08-23 |
Sponsor Name:Ana Vallejo De la Cueva | ||
Full Title: Dexmedetomidine versus current clinical practice for non-invasive mechanical ventilation: a randomized clinical trial | ||
Medical condition: Accute respiratory insuffienciency | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2015-000377-12 | Sponsor Protocol Number: CHUBX2014/26 | Start Date*: 2017-09-18 | ||||||||||||||||
Sponsor Name:CHU de Bordeaux | ||||||||||||||||||
Full Title: MISOBOLD - Prostate cancer hypoxia using BOLD MRI and 18F-FMISO PET imaging | ||||||||||||||||||
Medical condition: Prostate cancer | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: FR (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-001008-23 | Sponsor Protocol Number: RIOP-1 | Start Date*: 2014-09-26 | |||||||||||
Sponsor Name:The Newcastle Upon Tyne Hospital NHS Foundation Trust, Freeman Hospital | |||||||||||||
Full Title: Riociguat in patients with respiratory disease and hypoxia – a proof-of-concept study | |||||||||||||
Medical condition: Pulmonary hypertension WHO Group III (Pulmonary hypertension owing to lung disease and/or hypoxia): Chronic obstructive pulmonary disease(COPD); Pulmonary Fibrosis (PF). | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
